Suyi Li

First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

Yan Song, Bo Zhang, Dao Xin et al. · Nature Medicine · 2023 · 149 citations · Full text

Multifunctional tacrine–flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease

Suyi Li, Xiaobing Wang, Sai‐Sai Xie et al. · European Journal of Medicinal Chemistry · 2013 · 95 citations · Full text

Medicinal Chemistry, Multifunctional Tacrine–flavonoid Hybrids, Alzheimer's Disease +9

Design, synthesis and evaluation of novel tacrine–rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease

Suyi Li, Neng Jiang, Sai‐Sai Xie et al. · Organic & Biomolecular Chemistry · 2013 · 91 citations

Pharmaceutical Science, Organic Chemistry, Chemistry +17

Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease

Jinshuai Lan, Sai‐Sai Xie, Suyi Li et al. · Bioorganic & Medicinal Chemistry · 2014 · 74 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Alzheimer's Disease +10

Inhibition of Tumor Growth in Vitro by a Combination of Extracts from Rosa Roxburghii Tratt and Fagopyrum Cymosum

Wei Liu, Suyi Li, Xin‐En Huang et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 74 citations · Full text